 CLTI present with multisegment disease thereby complicating the
clinical decision-making usefulness of TASC recommendations. TASC is more reasonably
useful for assessing lesion-specific device performance.
The consensus was updated in 2007 (TASC II) and included representatives from Australia,
South Africa, and Japan.

Treatment
Treatment of CLTI includes conservative management and invasive intervention. Lifestyle
modification is recommended and highly encouraged and includes smoking cessation, regular
exercise, and a healthy diet to reduce cardiovascular